Financials data is unavailable for this security.
View more
Year on year Kontafarma China Holdings Ltd had revenues fall -9.50% from 894.06m to 809.11m, though the company grew net income from a loss of 41.55m to a smaller loss of 28.84m.
| Gross margin | 59.88% |
|---|---|
| Net profit margin | -10.40% |
| Operating margin | -8.21% |
| Return on assets | -4.95% |
|---|---|
| Return on equity | -5.79% |
| Return on investment | -6.40% |
More ▼
Cash flow in HKDView more
In 2023, cash reserves at Kontafarma China Holdings Ltd fell by 44.94m. However, Cash Flow from Investing totalled 144.14m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 37.12m in cash from operations while cash used for financing totalled 198.81m.
| Cash flow per share | 0.0018 |
|---|---|
| Price/Cash flow per share | 16.90 |
| Book value per share | 0.1904 |
|---|---|
| Tangible book value per share | 0.1033 |
More ▼
Balance sheet in HKDView more
| Current ratio | 1.47 |
|---|---|
| Quick ratio | 1.24 |
| Total debt/total equity | 0.2675 |
|---|---|
| Total debt/total capital | 0.2116 |
More ▼
Growth rates in HKD
Year on year, growth in earnings per share excluding extraordinary items increased 66.01%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -1,269.07 |
